Detalles de la búsqueda
1.
Targeting CD39 Toward Activated Platelets Reduces Systemic Inflammation and Improves Survival in Sepsis: A Preclinical Pilot Study.
Crit Care Med
; 47(5): e420-e427, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30730441
2.
Dual-Targeted Theranostic Delivery of miRs Arrests Abdominal Aortic Aneurysm Development.
Mol Ther
; 26(4): 1056-1065, 2018 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29525742
3.
A single-chain antibody-CD39 fusion protein targeting activated platelets protects from cardiac ischaemia/reperfusion injury.
Eur Heart J
; 39(2): 111-116, 2018 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28472483
4.
Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets.
Circ Res
; 114(7): 1083-93, 2014 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-24508759
5.
Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?
Blood
; 121(16): 3067-75, 2013 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-23380744
6.
Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice.
Circulation
; 125(25): 3117-26, 2012 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-22647975
7.
Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis--but does not affect immunity and thrombosis in mice.
Circ Res
; 109(11): 1269-79, 2011 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-21998326
8.
An activation-specific platelet inhibitor that can be turned on/off by medically used hypothermia.
Arterioscler Thromb Vasc Biol
; 31(9): 2015-23, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21659646
9.
Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target.
Arterioscler Thromb Vasc Biol
; 31(7): 1607-16, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21512161
10.
A Recombinant Fusion Construct between Human Serum Albumin and NTPDase CD39 Allows Anti-Inflammatory and Anti-Thrombotic Coating of Medical Devices.
Pharmaceutics
; 13(9)2021 Sep 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34575580
11.
A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense.
Nat Commun
; 9(1): 525, 2018 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29410422
12.
Targeting Activated Platelets: A Unique and Potentially Universal Approach for Cancer Imaging.
Theranostics
; 7(10): 2565-2574, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28819447
13.
Thrombus-Targeted Theranostic Microbubbles: A New Technology towards Concurrent Rapid Ultrasound Diagnosis and Bleeding-free Fibrinolytic Treatment of Thrombosis.
Theranostics
; 6(5): 726-38, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27022419
14.
In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications.
PLoS One
; 10(9): e0138375, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26381750
Resultados
1 -
14
de 14
1
Próxima >
>>